Related by context. All words. (Click for frequent words.) 71 ALN TTR 70 CYT# potent vascular disrupting 70 Phase 2b Clinical Trial 70 Immunotherapeutic 69 Personalized Immunotherapy 69 kidney urologic 68 RNAi Therapeutic 68 nucleotide analog 68 targeted radiotherapeutic 68 ALN PCS 68 FOLOTYN ® 68 PNP inhibitor 67 Initiates Phase II 67 NS5b 67 systemic fungal infections 67 Prodarsan R 67 Thiovir 67 Hepatitis B Virus 67 Vaccine Adjuvant 67 Therapeutic Vaccine 67 MEK Inhibitor 67 Phase 2b Trial 67 Hepatitis C HCV 67 Achieves Primary Endpoint 67 Phase III Clinical Trial 67 oral prodrug 67 IMiDs ® 67 Patient Enrollment 67 Pafuramidine 67 Phase IIb Clinical Trial 67 Initiates Clinical Trial 67 Initiates Clinical 67 Factor Receptor 67 HCV polymerase 67 Vaccine Candidate 67 CCR9 antagonist 67 Respiratory Virus 67 Meets Primary Endpoint 67 ARRY # 67 Completes Patient Enrollment 67 nasal decolonization 66 Initiate Clinical Trial 66 Entry Inhibitor 66 Alfacell proprietary ribonuclease 66 Drug Candidate 66 toenail onychomycosis 66 Maribavir 66 Receives Orphan Drug Designation 66 Initiates Enrollment 66 gastro intestinal inflammation 66 Monoclonal Antibody 66 platform HDL Mimetic 66 non nucleoside HCV 66 platinum chemotherapeutic 66 Pegloticase 66 JAK2 Inhibitor 66 myelofibrosis polycythemia vera 66 NS#/#A protease 66 Vicriviroc 66 rxRNA 66 Aganocide 66 Hsp# Inhibitor 66 Novel Oral 66 Pivotal Phase III 66 MVA BN R 66 Epidermal Growth Factor Receptor 66 Initiates Phase III 66 trastuzumab DM1 T DM1 66 Leukemias 66 Squalamine 66 investigational humanized monoclonal antibody 66 IMiDs ® compound 66 Xcytrin R 66 Respiratory Syncytial Virus RSV 66 Combination Therapy 66 Naive Patients 66 Shows Promise Against 65 human IgG1 monoclonal 65 Antibody Drug Conjugate 65 liposomal formulation 65 Solazed TM 65 therapeutic monoclonal antibodies 65 Presents Preclinical Data 65 Files IND 65 Epstein Barr Virus EBV 65 Cerebril TM 65 systemic RNAi therapeutic 65 Aurora Kinase 65 acetonide FA 65 HTS assay 65 Macrolide 65 Universal Flu Vaccine 65 Presents Positive 65 INS# [001] 65 visit www.genenews.com 65 Presents Preclinical 65 Demonstrates Significant 65 Recombinant interferon alpha 65 Cancer Vaccines 65 candidates Azedra TM 65 Omacetaxine 65 Vitrasert R 65 Severe Sepsis 65 delivers fluocinolone acetonide FA 65 PROSTASCINT R 65 non nucleoside inhibitor 65 hepatitis C HCV 65 lead molecular radiotherapeutic 65 StaphVAX R 65 ZFP Therapeutic 65 MyVax R 65 Altastaph 65 humanized monoclonal 65 Sudhir Agrawal D.Phil 65 Virulizin ® 65 RNAi therapeutic targeting 65 protein tyrosine phosphatase 1B 65 orally administered inhibitor 65 Hepatitis C Virus 65 Phase III Pivotal 65 ALN HPN 65 mertansine 65 Sapacitabine 65 Alvine Pharmaceuticals 65 targeting CD# 65 Microplasmin 65 Pivotal Trial 65 Cetrorelix 65 novel VDA molecule 65 Prolongs Survival 65 Civacir 64 MAGE A3 ASCI 64 Receives Milestone Payment 64 Vaccine Protects Against 64 Recombinant Human 64 chimeric monoclonal antibody 64 Phase 2a Clinical Trial 64 Receives Orphan Drug 64 AEG# 64 Completes Enrollment 64 Lymphocytic 64 Nitazoxanide 64 Small Molecule 64 Oral Calcitonin 64 First Patient Dosed 64 antibody MAb 64 Present Preclinical Data 64 Investigational Treatment 64 DermaVir Patch 64 Advanced Melanoma 64 Cethromycin 64 p# biomarker 64 Archexin 64 Protease Inhibitor 64 HDAC Inhibitor 64 Infected Patients 64 Improves Outcomes 64 ALN TTR# 64 Catheter Associated 64 hypereosinophilic syndrome 64 CCR5 mAb 64 Reports Preclinical Data 64 tiapamil 64 Blinatumomab 64 NS5A 64 anionic backbone 64 Anavex #-# 64 Single Dose 64 Pathway Inhibitor 64 Potelligent Technology 64 Atopic Dermatitis 64 MyVax ® 64 AFREZZA TM 64 methylnaltrexone bromide 64 ONCONASE R 64 MKC# MKC# PP 64 chemotherapy induced neutropenia 64 transthyretin TTR 64 candidates Azedra 64 dasatinib Sprycel ® 64 XmAb ® 64 forodesine 64 Phase IIb Trial 64 therapeutic monoclonal antibody 64 Chronic Hepatitis C 64 accumulate preferentially 64 Beta catenin pathway 64 RNAi Therapeutics 64 P#X# antagonist 64 TRANSDUR ™ 64 Talabostat 64 Begins Dosing 64 oral ghrelin agonist 64 Kinase Inhibitor 64 recurrent glioblastoma multiforme 64 Systemic Delivery 64 Familial Adenomatous Polyposis FAP 64 predictive biomarkers 64 CCR5 antagonist 64 Clinical Trial Results 64 non nucleoside 64 Disease Progression 64 posterior uveitis 64 Cutaneous T 64 cutaneous T 64 investigational oral inhibitor 64 Combination REOLYSIN R 64 DiLA2 64 PI3K/mTOR 64 Cytomegalovirus CMV 64 Successfully Completes Phase 63 ELADUR ™ 63 TTR amyloidosis 63 NDA Submission 63 product platforms AZX# 63 MKC# MT 63 oral picoplatin 63 hyperphenylalaninemia HPA due 63 synthetic retinoid 63 Tobira Therapeutics 63 JAK Inhibitor 63 TKB# 63 monoclonal antibody conjugated 63 Oncolytic 63 Pralatrexate 63 Demonstrates Positive 63 Ecallantide 63 IMiDs R 63 HCV protease inhibitor 63 combination antiretroviral therapy 63 simplex virus 63 Onalta 63 Patent Covering 63 product candidate Lpathomab 63 Novel Antibiotic 63 Metastatic Melanoma 63 topically applied SEPA 63 Hedgehog Pathway Inhibitor 63 diarrhea predominant irritable 63 SPRYCEL ® 63 Granted Orphan Drug 63 Drug Resistant 63 Factor VIIa 63 replicon 63 latent tuberculosis infection 63 MGd 63 Initiates Clinical Trials 63 OMNARIS HFA 63 Exelixis XL# 63 Chimigen TM 63 metaglidasen 63 molecular imaging radiopharmaceutical 63 Bosutinib 63 HCV Protease Inhibitor 63 AAG geldanamycin analog 63 Elvitegravir 63 nucleotide analogue 63 Panzem R 63 Bazedoxifene 63 Anti Tumor 63 Elotuzumab 63 Oral Mucositis 63 pralatrexate injection folate analogue 63 Investigational Compound 63 essential thrombocythemia ET 63 SMARTICLES ® 63 Asthma COPD 63 Diabetic Macular Edema 63 varicella zoster virus VZV 63 Fast Track Status 63 BENLYSTA TM 63 Aflibercept 63 mda 7 63 Novel Vaccine 63 LHRH antagonists 63 immunotherapeutic vaccine 63 IND Filing 63 Voreloxin 63 Chemokine Receptor 63 chronic eosinophilic leukemia 63 Vitro Activity 63 Liposomal 63 CCX# 63 Oritavancin 63 Pivotal Phase 63 attach auristatin 63 immunotherapeutic approaches 63 treat chronic sinusitis 63 metastatic colorectal 63 Valopicitabine 63 Perflubutane Polymer Microspheres 63 M2 subunit 63 Cardiotoxicity 63 Alferon LDO 63 BrachySil ™ 63 Drug Shows Promise 63 Bucindolol Based 63 Receives Fast Track 63 Aurexis 63 Complicated Skin 63 CTAP# Capsules 63 Molecular Diagnostic 63 Advanced Renal Cell 63 anti infective treatments 63 Soft Tissue Sarcoma 63 apoptosis inducer 63 Dendritic Cells 63 Progressive Multifocal Leukoencephalopathy 63 Azedra 63 histone deacetylase HDAC inhibitor 63 candidate XP# 63 Ridaforolimus 63 serogroup B 63 Solazed ™ 63 CYP#A# CYP#D# 63 TRANSDUR ® 63 inhibit replication 63 Presents Positive Preclinical 63 delta isoform 63 cMET 63 Initiates Phase 2b 63 GVAX ® 63 First Patient Treated 63 Clinical Validation 63 including eniluracil ADH 63 Heart Transplant Recipients 63 p# inhibitor 63 OHR/AVR# 63 Veronate R 63 dasatinib Sprycel 63 castrate resistant prostate cancer 63 Demonstrates Sustained 63 radezolid 63 Elagolix 63 HuMax TAC 63 Tesetaxel 63 Pegylated 63 recombinant biopharmaceutical 63 Phase #b/#a clinical 63 candidate deforolimus 63 Replacement Therapy 63 HCV RNA polymerase 63 Protein Interactions 62 Antibody Discovery 62 Tumor Targeting 62 Onalta TM 62 multi kinase inhibitor 62 fibrotic disorders 62 Selective Electrochemical Tumor Ablation 62 Files Investigational 62 PGL# 62 Vascugel 62 Dupuytren Contracture 62 hormone LHRH antagonist 62 Janus kinase 62 PRTX 62 Intravenous Human 62 Anthracycline 62 Virus Infection 62 Trodusquemine MSI 62 CINTREDEKIN BESUDOTOX 62 ZFP Therapeutics 62 proprietary BiTE ® 62 herpes zoster shingles 62 apricitabine ATC 62 T#I [002] 62 thetreatment 62 Extracellular Matrix 62 Vitrasert ® 62 Earns Milestone Payment 62 evaluating tivozanib 62 Dasatinib 62 Polymerase Inhibitor 62 Phase 2a Trial 62 Therapy Evaluation 62 Viread tenofovir disoproxil fumarate 62 oropharyngeal candidiasis OPC 62 Cathepsin S 62 autologous cellular immunotherapy 62 Patients Treated With 62 Protein Kinase C 62 Ibis T# TM 62 Tyrosine Kinase Inhibitor 62 metastatic neuroendocrine tumors 62 NASH Huntington 62 nucleotide analog polymerase inhibitor 62 Telbivudine 62 Albuferon TM 62 Interferon Gamma 62 virosome 62 secretory phospholipase A2 62 CEQ# 62 Systemic lupus erythematosus 62 Epstein Barr virus EBV 62 Onconase 62 CysDisplay R 62 biologic therapeutics 62 selective modulator 62 Submits Supplemental 62 Protexia R 62 leading oral taxane 62 delafloxacin 62 Trichomonas vaginalis 62 NurOwn 62 NS5B polymerase 62 LNP formulations 62 HDL Mimetic Peptide 62 Neisseria gonorrhoeae 62 Dalbavancin 62 NPM1 mutation 62 Multicenter Randomized 62 Fleximer R 62 siRNA therapeutics 62 PKC# 62 KL4 Surfactant 62 Treating Chronic 62 Stapled Peptide 62 DNA RNA Medicines 62 LymphoStat B belimumab 62 huC# DM4 62 HDL Selective Delipidation 62 ABL inhibitor 62 vinca alkaloid 62 Investigational Oral 62 proprietary capillary aerosolization 62 HyACT 62 Lenocta 62 Aliskiren 62 nucleotide analogs 62 Myelodysplastic Syndrome MDS 62 ALTROPANE R 62 CINQUIL 62 ATL# [002] 62 relapsing remitting MS RRMS 62 Pivotal Clinical Trial 62 candidate CRLX# 62 NRTI resistance 62 agonistic human 62 Treatment Naïve 62 Prodrug 62 Pandemic Influenza Vaccine 62 sulfonylhydrazine class 62 lucinactant 62 Locked Nucleic Acid LNA 62 visit http:/www.mannkindcorp.com 62 Gets FDA Clearance 62 enhance ApoA 62 torezolid 62 Preclinical Data 62 Antitumor Activity 62 rusalatide acetate 62 oncolytic virus therapies 62 Prophylactic Treatment 62 Announces Poster Presentations 62 Fabry Disease 62 receptor tyrosine kinase inhibitor 62 Tezampanel 62 Completes Dosing 62 MEK inhibitor 62 VitiGam TM 62 Ramoplanin 62 Hepatocellular Carcinoma 62 peptidic compound 62 Pivotal Study 62 Amphotericin B 62 VitiGam 62 Phase Ib IIa 62 Develop Novel 62 lymphoid malignancies 62 Submits NDA 62 JAK inhibitor 62 Squamous 62 TRO# 62 refractory chronic lymphocytic 62 Circulating Tumor Cells 62 Renal Cell Carcinoma 62 Onalta ™ 62 MTP inhibitor 62 Phase 2a clinical trials 62 Cloretazine ® 62 Phase 2a Study 62 Fidaxomicin 62 herpetic keratitis 62 Molecular Diagnostic Test 62 novel emulsion formulation 62 Phase III Trial 62 novel peptides 62 immunoregulation 62 HCV NS5B polymerase 62 Valortim TM 62 Successfully Treated 62 Nicotine Conjugate Vaccine 62 Curaxin 62 IRX 2 62 cytomegalovirus CMV 62 Uvidem 62 Aviptadil 62 Soliris eculizumab 62 oral dihydropyrimidine dehydrogenase DPD 62 luliconazole 62 Atripla combines 62 R#/MEM # 62 resistant hormone refractory 62 evaluating picoplatin 62 developing TB4 62 ThermoDox R 62 Zemiva TM 62 IMA# 62 acyclovir Lauriad R 62 Commercialize Novel 62 Interferon Beta 62 invasive candidiasis 62 ketolide antibiotic 62 vidofludimus 62 Genotyping Test 62 ORADUR ® 62 recombinant subunit vaccine 62 ProLindac TM 62 Amgen Neulasta R 62 INVANZ 62 Isavuconazole 62 R#/MEM 62 latent tuberculosis TB 62 Lupus Nephritis 62 HuCAL GOLD R 61 ADP receptor antagonist 61 Phase 1b Clinical Trial 61 SinuNase ™ 61 Safinamide 61 Curaxin CBLC# 61 Hemopurifier ® 61 Malignant Melanoma 61 Randomized Double blind 61 systemic anaplastic large 61 Transdrug ® nanoparticle 61 OTCBB PYTO 61 sapropterin dihydrochloride 61 Antiangiogenic 61 Antiviral Activity 61 Bronchiectasis 61 REMOXY ® 61 Initiate Phase 61 VivaGel ™ 61 Initiates Dosing 61 Nasdaq XTLB 61 Treatment Shows Promise 61 Medical Countermeasure 61 PDX pralatrexate 61 Aganocide ® 61 Symadex 61 myelodysplastic myeloproliferative diseases 61 small molecule Hedgehog 61 clade B 61 developing Bicifadine serotonin 61 FDA Accepts 61 Protexia ® 61 DIFICID ™ 61 Transdermal Patch 61 romazarit 61 Eculizumab 61 Gastrointestinal Stromal Tumors 61 immuno therapeutic 61 Apaziquone 61 Announce License Agreement 61 Gamunex C 61 reverse transcriptase inhibitors 61 Curaxins 61 cardio renal 61 Nilotinib 61 virus HCV protease inhibitor 61 PEGylated Fab fragment 61 CD# expressing 61 refractory gout 61 Bucindolol 61 Methylnaltrexone 61 Ceragenin ™ 61 Submits IND 61 Tumour Vascular Disrupting Agent 61 Zysolin TM 61 Golimumab 61 drugable targets 61 VivaGel TM 61 Recombinant Protein 61 aerosolized AAT 61 Moxifloxacin 61 Demonstrates Efficacy 61 Ozarelix 61 PANVAC VF 61 alkylating agent 61 pharmacological chaperone 61 imatinib Gleevec ® 61 Pooled Analysis 61 signal transduction inhibitors 61 Varicella Zoster 61 EHT AGN 61 Escherichia coli Klebsiella pneumoniae 61 Maven Semantic 61 EVIZON TM 61 PROGENSA R 61 successfully commercialize Iluvien 61 Preclinical Efficacy 61 IL# PE#QQR 61 TNF Tumor Necrosis Factor 61 Phase IIb clinical trials 61 Efficacy Trial 61 IMPACS R 61 HQK 61 Develops Novel 61 CCR5 tropic 61 Chlamydia trachomatis 61 JAK2 inhibitor 61 #I TM# 61 PORxin TM 61 XL# XL# 61 HuLuc# 61 Iluvien ® 61 Celgosivir 61 CRMD# 61 intravesical infusion therapy 61 Transdermal Delivery 61 topically administered 61 novel oral anticoagulant 61 null responder 61 oral nucleoside analogue 61 MT#/MEDI-# 61 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 61 signal transduction inhibitor 61 Tesamorelin 61 SIX RO ROG 61 ara C 61 Shows Promising 61 HBeAg negative 61 Immunomedics Announces 61 Diabetic Foot Ulcer 61 BUPHENYL R 61 selective androgen receptor modulator 61 BXT # 61 novel immunotherapies 61 oral proteasome inhibitor 61 Taxane 61 Xyfid TM 61 small molecule activators 61 lipid nanoparticle 61 Regenerative Cells 61 LymphoStat B TM 61 Palifosfamide 61 Therapeutic Vaccines 61 Orally administered 61 MKC# 61 Diabetic Neuropathy 61 Vicinium TM 61 Receives Approvable Letter 61 Alferon N 61 generation purine nucleoside 61 HGS ETR1 mapatumumab 61 Viral Load 61 Systemic Sclerosis 61 Oral Fingolimod 61 Prodarsan ® 61 Novel Therapeutic 61 NEUGENE 61 lenalidomide Revlimid R 61 HCV protease inhibitors 61 non porcine pancreatic 61 Dupuytren Disease 61 Acute Radiation Syndrome 61 Chronic Myeloid Leukemia 61 BAL# [001] 61 LEAPS TM 61 First Patient Enrolled 61 Pharmacokinetics PK 61 oncolytic viruses 61 Behcet uveitis 61 SNT MC# 61 novel immunomodulatory 61 selective S#P# receptor agonist 61 Oracea TM 61 CMV vaccine 61 Chronic Hepatitis B 61 sodium glucose cotransporter 61 Acute Heart Failure 61 miconazole Lauriad ® 61 investigational monoclonal antibody 61 Previously Treated 61 Synthetic Peptide 61 humanized monoclonal antibodies 61 non alcoholic steatohepatitis 61 Pneumocystis pneumonia PCP 61 PRT# 61 Hodgkin lymphoma HL 61 SPL# Gel vaginal microbicide 61 isoform selective 61 Atypical Hemolytic Uremic Syndrome 61 budesonide foam 61 tubulin inhibitor 61 Orally Active 61 Temsirolimus 61 Epratuzumab 61 J Am Coll 61 PSMA ADC 61 Cleviprex TM clevidipine 61 SinuNase TM 61 HuCAL PLATINUM ® CysDisplay 61 volociximab 61 ulimorelin 61 Liprotamase 61 lexidronam injection 61 infectious diseases autoimmune diseases 61 Demonstrates Potential 61 CINtec R 61 topical anti infective 61 including thyroiditis RA 61 Gleevec resistant 61 Bioral Amphotericin B 61 Immunotherapies 61 Daclizumab 61 Trial Evaluating 61 co receptor tropism 61 Commences Phase 61 Protein Expression 61 Pruvel TM 61 anticancer therapeutics 61 intranasal formulation 61 CTAP# 61 VIVITROL ® 61 Hemopurifier 61 sodium thiosulfate STS 61 thiazolides 61 Daptomycin 61 HIV coinfected 61 personalized cellular immunotherapy 61 flu mAb 61 Serious Infections 61 Hematopoietic 61 BCG refractory carcinoma 61 leukotriene pathway 61 Immunosuppressive 61 Apoptone 61 cleavable linker 61 Factor Xa Inhibitor 61 PHX# 61 dextofisopam 61 Warfarin Coumadin 61 molecular diagnostic assay 61 XOMA 3AB 61 mGluR5 negative 61 anticoagulant reversing agent 61 Prospective Randomized 61 vaginal candidiasis 61 HIV integrase inhibitors 61 anti secretory 61 Successfully Treats 61 POSIDUR TM ELADUR TM 61 Trofex 61 EP #R 61 topical non steroidal 61 Shigatoxin producing E. coli 61 Tigecycline 61 biodefense pathogens 61 Deforolimus 61 Treatment Naive Patients 61 Trastuzumab DM1 61 Hospital Acquired Pneumonia 61 transthyretin TTR mediated amyloidosis 61 pan HDAC inhibitor 61 Pyridorin 61 Telatinib 61 Panzem 61 Randomized Clinical Trials 61 engineered RAP peptides 61 Xanafide 61 BARACLUDE R 61 HER2 overexpression 61 XYOTAX TM 61 Confirms Efficacy 61 personalized immunotherapy 61 JAK1 61 Hormone Refractory Prostate Cancer 61 epithelial tumors 61 subsidiaries visit http:/www.apricusbio.com 61 cryptococcosis 61 purinergic receptors P#X# 61 endoluminal stent graft 61 MDRNA proprietary 61 virus AAV 60 R Saizen R 60 Mg Usa 60 diagnostic molecular imaging 60 vinorelbine tartrate 60 IONSYS TM 60 Chronic HCV 60 Multiple Sclerosis Rheumatoid Arthritis 60 Intravenous CP 60 JAK inhibitors 60 gastrointestinal stromal tumors GIST 60 valent pneumococcal conjugate vaccine 60 MOVIPREP R 60 Nonalcoholic fatty liver 60 sunitinib Sutent ® 60 sapropterin dihydrochloride Tablets 60 BAL# [002] 60 Initiates Phase 60 SAR# [004] 60 HCV NS3 protease 60 Benign Prostatic Hyperplasia 60 ALV# 60 IgG1 monoclonal antibody 60 Evoltra ® 60 M# rationally 60 AA Amyloidosis 60 Epigenomics proprietary 60 Oral Fluid 60 POTELLIGENT ® 60 MorphoSys proprietary 60 IAP inhibitor 60 Intravesical 60 novel therapeutic antibodies 60 nonnucleoside reverse transcriptase inhibitors 60 Immune Mediated 60 Study Evaluating 60 Progenitor Cells 60 Tumor Response 60 Alemtuzumab 60 Aztreonam 60 Ph.D. Targacept 60 delivery polymer matrix 60 CYC# 60 polysaccharide polymer 60 Septin9 biomarker 60 topoisomerase II inhibitor 60 recurrent metastatic ovarian cancer 60 fluoroquinolone antibiotic 60 FDA Approvals 60 methicillin resistant S. aureus 60 antimitotic 60 metastatic malignant 60 Glufosfamide 60 Provectus Pharmaceuticals specializes 60 Preclinical Study 60 vapreotide acetate 60 Mouse Model 60 Fludara ® 60 Plaque Psoriasis 60 TRX1 60 polymerase inhibitors 60 methicillin susceptible Staphylococcus aureus 60 please visit http:/www.vandapharma.com 60 Aganocide TM 60 Rotavirus Vaccine 60 virus HCV infection 60 Endologix Powerlink System 60 Ceflatonin R 60 JVRS 60 PEG SN# 60 Hypercholesterolemia 60 LibiGel ® 60 interferon gamma 1b 60 oral Janus kinase 60 HBV HCV 60 compound AEOL # 60 Degarelix 60 Hepatitis C virus HCV 60 Idiopathic Pulmonary Fibrosis 60 Renin Inhibitor 60 SuperAntibody 60 highly purified pasteurized 60 Systemic lupus erythematosus SLE 60 intranasal delivery 60 A3 adenosine receptor 60 OncoVex 60 Kamada AAT 60 ARIKACE ™ 60 Faropenem 60 adenoviral vectors 60 VBLOC TM 60 Begin Clinical Trials 60 Adjuvant Treatment 60 Overactive Bladder 60 sapacitabine CYC# 60 nucleoside analog 60 stable nucleic acid 60 generation PNP inhibitor 60 Therapeutic Antibody 60 catheter occlusion 60 Friedreich Ataxia FRDA 60 Anticalins R 60 polymerase inhibitor 60 Randomized Phase II 60 investigational integrase inhibitor 60 TransVax TM 60 Frozen Shoulder Syndrome 60 IAP inhibitors 60 Therapeutic Competitors Companies 60 Marqibo TM 60 plasma kallikrein inhibitor 60 OMP #R# 60 AN# novel 60 Spiegelmer ® 60 Unresectable 60 relapsed leukemia 60 Associated Adipose Redistribution 60 SNT-MC#/idebenone 60 Novosom 60 Alexza Staccato 60 HepaGam B 60 herpes simplex viruses 60 Vascular Disrupting Agent 60 5 HT2A inverse 60 Fc fusion protein 60 Romidepsin 60 IMC #B 60 vivo fluorescence imaging 60 proprietary PEGylation 60 immune modulating 60 lymphoid tumors 60 HPV-#/# 60 Zorbtive TM 60 TLK# 60 Cytomegalovirus 60 Sangamo BioSciences Announces 60 investigational therapies 60 Benign Prostatic Hyperplasia BPH 60 Treatment Experienced 60 pediatric acute lymphoblastic 60 Tyrima 60 Therapeutic Targets 60 acyclovir Lauriad ® 60 Chronic Sinusitis 60 phase IIb trial 60 Monotherapy 60 Interferon Alpha 60 FGFR 60 faropenem medoxomil 60 tkRNAi 60 NovaBay Aganocide compounds 60 Serostim ® 60 humanized antibody 60 cell lymphoma CTCL 60 sirtuin inhibitor program 60 pigmentary disorders 60 ospemifene 60 5 HT3 antagonist 60 Traficet EN 60 targeting PCSK9 60 targeted antifolate 60 antibiotics antifungals 60 BiTE Antibody 60 CR# vcMMAE 60 diagnostic biomarkers 60 panitumumab Vectibix 60 immunodeficiency disorders 60 Nasulin ™ 60 Myelodysplastic Syndromes 60 Tß4 60 Test Detects 60 injectable bulking agent 60 tyrosine kinase inhibitor TKI 60 FUSILEV ® 60 Oral Insulin 60 Diabetic Neuropathic Pain 60 HCV Genotype 60 Vascular Inflammation 60 antisense inhibitors 60 Cloretazine 60 Quinamed 60 AzaSite TM 60 monoclonal antibody MAb 60 BrachySil TM 60 modified glutathione analog 60 Patients Receiving 60 proprietary radiolabeled monoclonal 60 immune modulatory 60 advanced metastatic renal 60 CCR5 receptor antagonist 60 molecular biomarkers 60 omega interferon 60 Pimavanserin 60 Tofacitinib 60 R MSCRAMM 60 invasive aspergillosis 60 documented candidiasis 60 Enzyme Replacement Therapy 60 Improves Survival 60 anticancer compound 60 Fleximer 60 Malaria Vaccine 60 Lupus Drug 60 ELND-#/AZD-# 60 Investigational Drug 60 Phase IIa Clinical Trial 60 MVA BN ® 60 Tyrosine Kinase Inhibitors 60 immune stimulatory 60 Radezolid 60 pharmacogenomic translational research 60 XIAFLEX ® 60 VeraTag 60 Cerashield 60 novel antiviral therapeutics